Illumina sequencing and array technologies drive advances in life science research, translational and consumer genomics, and molecular diagnostics.

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated …

Oct 31, 2025 · Shares of genomics company Illumina (NASDAQ:ILMN) jumped 22.4% in the afternoon session after it reported third-quarter 2025 financial results that beat profit …

5 days ago · Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function.

6 days ago · Following trade talks in Malaysia last week, the Chinese Ministry of Commerce said it will lift the import restrictions on Illumina's sequencers on Nov. 10.

6 days ago · Illumina will continue to engage with authorities and stakeholders as we work toward a long-term resolution," said Jacob Thaysen, CEO of Illumina.

Illumina Ventures is the leader in genomics and precision health investing. We are building the ecosystem and translating investment into innovation as we accelerate the impact on human …

We are Illumina We are a global genomics and human health leader innovating the future of precision health. We develop DNA sequencing and array-based life sciences technologies to …

Oct 31, 2025 · Illumina outlines path to high single-digit revenue growth and 20% margins by 2027 amid NovaSeq X acceleration Oct. 30, 2025 10:27 PM ET Illumina, Inc. (ILMN) Stock AI …

Mar 4, 2025 · Illumina cuts workforce at San Diego headquarters The local gene sequencing company cited cost savings to align with its future business strategy.